IDEXX LABORATORIES INC /DE Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IDEXX LABORATORIES INC /DE for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 38.80 | 50,000 | 1,939,750 | 40,000 | |
| Feb 23 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 2,286 | 99,921 | 0 | |
| Feb 23 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 142.84 | 3,205 | 457,808 | 1,010,947 | 1 M to 1 M (-0.32 %) |
| Feb 23 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 142.55 | 31,795 | 4,532,326 | 1,014,152 | 1 M to 1 M (-3.04 %) |
| Feb 23 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 38.80 | 50,000 | 1,939,750 | 1,045,947 | 995.9 K to 1 M (+5.02 %) |
| Feb 23 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 2,286 | 99,921 | 995,947 | 993.7 K to 995.9 K (+0.23 %) |
| Feb 21 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 53.19 | 1,880 | 99,988 | 3,760 | |
| Feb 21 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 53.19 | 1,880 | 99,988 | 38,548 | 36.7 K to 38.5 K (+5.13 %) |
| Feb 21 2017 | IDXX | IDEXX LABORATORIES ... | END WILLIAM T | Director | Sell | S | 141.71 | 5,000 | 708,534 | 50,256 | 55.3 K to 50.3 K (-9.05 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 406 | 0 | 4,868 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 346 | 0 | 5,274 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 282 | 0 | 5,620 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 327 | 0 | 5,902 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 342 | 0 | 6,229 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | A | 0.00 | 1,059 | 0 | 6,571 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | A | 141.60 | 706 | 99,970 | 706 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | A | 141.60 | 10,386 | 1,470,658 | 10,386 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Payment of Exercise | F | 141.60 | 575 | 81,420 | 18,857 | 19.4 K to 18.9 K (-2.96 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 406 | 0 | 19,432 | 19 K to 19.4 K (+2.13 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 346 | 0 | 19,026 | 18.7 K to 19 K (+1.85 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 282 | 0 | 18,680 | 18.4 K to 18.7 K (+1.53 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 327 | 0 | 18,398 | 18.1 K to 18.4 K (+1.81 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 342 | 0 | 18,071 | 17.7 K to 18.1 K (+1.93 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 406 | 0 | 7,103 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 346 | 0 | 7,509 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 0.00 | 1,059 | 0 | 7,855 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 141.60 | 706 | 99,970 | 706 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | A | 141.60 | 10,386 | 1,470,658 | 10,386 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 141.60 | 273 | 38,657 | 3,496 | 3.8 K to 3.5 K (-7.24 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 406 | 0 | 3,769 | 3.4 K to 3.8 K (+12.07 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 346 | 0 | 3,363 | 3 K to 3.4 K (+11.47 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 737 | 0 | 12,295 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 472 | 0 | 13,032 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 403 | 0 | 13,504 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 545 | 0 | 13,907 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | A | 0.00 | 2,295 | 0 | 14,452 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | A | 141.60 | 706 | 99,970 | 706 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | A | 141.60 | 23,326 | 3,302,962 | 23,326 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Payment of Exercise | F | 141.60 | 719 | 101,810 | 17,083 | 17.8 K to 17.1 K (-4.04 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 737 | 0 | 17,802 | 17.1 K to 17.8 K (+4.32 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 472 | 0 | 17,065 | 16.6 K to 17.1 K (+2.84 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 403 | 0 | 16,593 | 16.2 K to 16.6 K (+2.49 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 545 | 0 | 16,190 | 15.6 K to 16.2 K (+3.48 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 811 | 0 | 14,515 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 629 | 0 | 15,326 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 726 | 0 | 15,955 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 2,295 | 0 | 16,681 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 141.60 | 706 | 99,970 | 706 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 141.60 | 23,326 | 3,302,962 | 23,326 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 141.60 | 809 | 114,554 | 36,668 | 37.5 K to 36.7 K (-2.16 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 811 | 0 | 37,477 | 36.7 K to 37.5 K (+2.21 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 629 | 0 | 36,666 | 36 K to 36.7 K (+1.75 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 726 | 0 | 36,037 | 35.3 K to 36 K (+2.06 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 0.00 | 1,774 | 0 | 5,708 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 0.00 | 2,160 | 0 | 7,482 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 0.00 | 2,400 | 0 | 9,642 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | A | 141.60 | 706 | 99,970 | 706 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | A | 141.60 | 110,211 | 15,605,878 | 110,211 | |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Payment of Exercise | F | 141.60 | 3,159 | 447,314 | 993,661 | 996.8 K to 993.7 K (-0.32 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 0.00 | 1,774 | 0 | 996,820 | 995 K to 996.8 K (+0.18 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 0.00 | 2,160 | 0 | 995,046 | 992.9 K to 995 K (+0.22 %) |
| Feb 16 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 0.00 | 2,400 | 0 | 992,886 | 990.5 K to 992.9 K (+0.24 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 26.66 | 9,924 | 264,524 | 0 | |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 142.24 | 970 | 137,971 | 35,311 | 36.3 K to 35.3 K (-2.67 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 141.57 | 8,954 | 1,267,620 | 36,281 | 45.2 K to 36.3 K (-19.79 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 26.66 | 9,924 | 264,524 | 45,235 | 35.3 K to 45.2 K (+28.10 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 26.66 | 36,250 | 966,244 | 0 | |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 142.20 | 4,756 | 676,277 | 990,486 | 995.2 K to 990.5 K (-0.48 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 141.55 | 31,494 | 4,457,894 | 995,242 | 1 M to 995.2 K (-3.07 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 26.66 | 36,250 | 966,244 | 1,026,736 | 990.5 K to 1 M (+3.66 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 64.69 | 3,000 | 194,070 | 2,964 | |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 141.76 | 3,000 | 425,264 | 2,495 | 5.5 K to 2.5 K (-54.60 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 64.69 | 3,000 | 194,070 | 5,495 | 2.5 K to 5.5 K (+120.24 %) |